PharmaCyte Biotech Inc (PMCB)

[MOangler]

Thanks Pete. You always do good research. Here is an excerpt:

On October 28, 2014, the Company’s Registration on Form S-3 was declared effective by the Commission for a public offering of up to $50 million on a “shelf offering” basis. During the six months ended October 31, 2016 and 2015, the Company sold and issued approximately 66.8 and 14.7 million shares of common stock, respectively, at prices ranging from $0.02 to $0.16 per share. Net of underwriting discounts, legal, accounting and other offering expenses, the Company received proceeds of approximately $1.3 and $1.7 million from the sale of these shares for the six months ended October 31, 2016 and 2015, respectively. The Company has filed a prospectus supplement for an “at-the-market” offering with an investment bank as sales agent. As of October 31, 2016, the Company did not meet the eligibility requirements in order for it to be able to conduct a primary offering of its common stock under Form S-3 or to file a new Registration Statement on Form S-3. See Note 2 for additional information.

66.8 millions shares between May and October of 2016...Who says there has been no dilution? Is the company lying in an SEC filing when it says it sold these shares? Any guess why the SP went into the 2's?